http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-334451-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
filingDate 2005-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5b3569c21a68ce93793b37f5e51063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e7e6bb7b2e7a338fb9de3b15ff920c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a5467af97cf3e20cb286519f6253265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f38f470d4c8849b1e82624068770651
publicationDate 2014-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-334451-B1
titleOfInvention Medication for use in preventing and / or treating hypertension or arteriosclerosis and using the ingredients for the manufacture of a medicament for such use.
abstract A medicine for the prevention and / or treatment of arteriosclerosis, hypertension, heart failure, kidney failure or cerebrovascular disease. It comprises the following ingredients as active ingredients: (A) an angiotensin II receptor antagonist selected from the group consisting of a compound represented by the following formula (I), pharmacologically acceptable esters thereof and pharmacologically acceptable salts thereof (for example olmesartan medoxomil); and (B) a calcium antagonist selected from the group consisting of 1,4-dihydropyridine compounds and pharmacologically acceptable salts thereof (for example azelnidipine).
priorityDate 2003-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559194

Total number of triples: 24.